Targeting fat-tissue hormone may lead to type 2 diabetes treatment
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, ...
Dec 23, 2015
0
70